We report that serum holotranscobalamin (holoTC) compares favorably with serum vitamin B 12 for identifying vegans likely to have vitamin B 12 deficiency as judged by measurements of the metabolites methylmalonic acid (MMA) and homocysteine (tHcy). We also report that measurement of holoTC may possibly replace combined testing with serum vitamin B 12 (B12), MMA, and tHcy in this population.
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Recently, two new markers for vitamin B 12 deficiency, holoTC (TC saturated with vitamin B 12 ) and the related TC saturation (the fraction of total TC present as holoTC), have been introduced (1) (2) (3) . Approximately 30% of circulating B12 is attached to TC, whereas the major part of B12 is attached to another protein, haptocorrin. Because only B12 attached to TC (holoTC) is able to enter all the cells of the body, holoTC may be a more useful marker than total B12 in serum.
We compared holoTC with the tests currently used for diagnosis of vitamin B 12 deficiency, i.e., B12, MMA, and tHcy, in vegan men, whose diets are devoid of food of animal origin (and thus low in vitamin B 12 ) and who thus are susceptible to developing B12 deficiency.
The vegan men were recruited from two sources: 100 (of a subset of 233) vegan men enrolled in the Oxford cohort of the EPIC study ( Serum total TC and holoTC were measured by an ELISA (2 ) modified for use on an automated analyzer (BEP-2000; Dade Behring) at 37°C. The reference intervals for 161 blood donors (age interval, 21-65 years) were 700-1500 pmol/L for total TC, Ն50 pmol/L for holoTC, and Ն0.05 for TC saturation. The assay imprecision (CV) was 4% for holoTC, 6% for total TC, 8% for MMA and folate, and 5% for tHcy and B12, as judged by internal quality-control systems. Analysts performing the holoTC assays were unaware of the other results and vice versa.
MMA (reference interval, 0 -0.28 mol/L) and tHcy (reference interval, 0 -12 mol/L) were measured by gas chromatography-mass spectrometry (4 ). Serum folate (reference interval, 3-13 g/L) and B12 [reference interval Ն180 ng/L (Ն135 pmol/L)] were measured on an Immuno 1 analyzer (Bayer Diagnostics). Two vegans and one omnivorous individual had serum folate concentrations below the reference interval. Parietal cell and intrinsic factor antibodies were analyzed in all individuals with B12 Ͻ120 ng/L, but none was positive.
Statistical analyses were conducted using Prism 4 (GraphPad Software): between-group comparisons were made using a Mann-Whitney test; associations were tested using Pearson's correlation coefficient; and ROC curves and areas (with 95% CI) were used to estimate diagnostic accuracy for holoTC and B12.
HoloTC (median and range) was significantly lower (P Ͻ0.000001) in vegan men [41 (8 - (5, 6 ) and vegans (7 ), the severity was more marked in the present study, possibly because the individuals had followed their diets for longer.
HoloTC correlated strongly to TC saturation (r ϭ 0.96; P Ͻ0.0001). For this reason, only holoTC was included in further statistical analysis. Both holoTC and B12 showed similar negative correlations with MMA and tHcy (r ϭ Ϫ0.70 and Ϫ0.66, respectively, for correlation with MMA; r ϭ Ϫ0.69 and Ϫ0.67, respectively, for correlation with tHcy; see the Data Supplement that accompanies the online version of this Technical Brief at http:// www.clinchem.org/content/vol49/issue12/). B12 was strongly correlated with holoTC (r ϭ 0.75), as were MMA and tHcy (r ϭ 0.72). The strong correlation between Technical Briefs holoTC and B12 is in agreement with recently published results (8 ) . The correlations between MMA and both holoTC and B12 are in agreement with a previous study on vegetarians and vegans (7 ), but they are considerably stronger than observed for other target groups (9, 10 ) . A likely explanation for this difference is that the vegetarians/vegans suffer from no competing condition, whereas this may very well be the case in other population groups with suspected vitamin B 12 deficiency. (Table 1A) . HoloTC was significantly (P Ͻ0.01) lower in the group of vegan men unlikely to have vitamin B 12 deficiency compared with omnivores, whereas this was not the case for B12 (P ϭ 0.30; Table 1A ).
Finally we examined whether holoTC might replace combined testing with B12, MMA, and tHcy. In this analysis, individuals were classified as likely to have vitamin B 12 deficiency if at least two of three tests were outside the cutoff limits (B12 Ͻ120 ng/L, MMA Ͼ0.75 mol/L, tHcy Ͼ15 mol/L; n ϭ 56) or not (n ϭ 139; all others). The diagnostic accuracy of holoTC was then assessed by ROC curve analysis (Fig. 1B) . The areas under the ROC curves were 0.91 (95% CI, 0.87-0.95) for all individuals, 0.88 (95% CI, 0.82-0.95) for vegan men recruited from the EPIC study, and 0.92 (95% CI, 0.85-0.99) for the men recruited from the London Vegan Society.
We also compared holoTC and the other three markers in omnivores and in vegan men classified as unlikely to be, uncertain to be, or likely to be vitamin B 12 deficient based on test results for B12, MMA, and tHcy (Table 1B) . HoloTC was significantly lower (P ϭ 0.017) in the vegan men who were unlikely to be vitamin B 12 deficient compared with the omnivores, whereas no significant difference was observed for the other three measures: B12 (P ϭ 0.49), MMA (P ϭ 0.37), and tHcy (P ϭ 0.47).
Each of the laboratory tests used for diagnosis of vitamin B 12 deficiency has its weaknesses. The metabolites MMA and tHcy are influenced by kidney function (10, 11 ) , and tHcy also depends on the folate status of the patient. B12 is influenced by the concentration of the binding proteins of vitamin B 12 and is increased in patients with myeloproliferative diseases (12 ) .
Our data are consistent with an early decrease of holoTC in vitamin B 12 deficiency in vegans and further suggest that holoTC might replace combined testing with B12, MMA, and tHcy in this population group. If holoTC is used as the primary screening test, we suggest no further testing for patients with holoTC Ͼ50 pmol/L (unlikely to suffer from vitamin B 12 deficiency) and holoTC Ͻ25 pmol/L (likely to suffer from vitamin B 12 deficiency). For patients with holoTC between 25 and 50 pmol/L, we would suggest further testing with one of the metabolic markers.
Further studies are needed to evaluate the validity of holoTC in other patient groups, especially those with conditions likely to influence markers of vitamin B 12 deficiency. Measurement of holoTC may be of particular value in identifying vitamin B 12 deficiency in patients with kidney malfunction, in whom the metabolites may show falsely increased values (10, 11 ) , and in patients with myeloproliferative diseases, in whom the concentration of B12 may be falsely increased (12 ) . We conclude that holoTC is a promising indicator of vitamin B 12 deficiency.
